Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Joyance Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
Joyance Partners

Joyance Partners

Operating

Joyance Partners: A venture capital firm investing in companies creating 'Delightful Moments'.

Location
San Francisco, CA, US
Founded
2017
Firm
Compare
Portfolio
Employees
Website

Investments

Sunnyside
Sunnyside

Total Raised

$14.6M

Rounds

3

Series A$11.5MNovember 2023
Mosh
Mosh

Total Raised

$3M

Rounds

1

Series A$3MAugust 2023
Scent Lab
Scent Lab

Rounds

1

Pre-SeedJune 2023
Cuzen Matcha
Cuzen Matcha

Total Raised

$4.6M

Rounds

3

Series A$3.6MJune 2023
Cure
Cure

Total Raised

$8.2M

Rounds

3

Series A$5.6MApril 2023
Wave
Wave

Total Raised

$10M

Rounds

3

Seed$6MMarch 2023
Phyla
Phyla
Series A

Total Raised

$3.2M

Rounds

6

Seed$2MJuly 2022
Epicore Biosystems
Epicore Biosystems

Total Raised

$9.8M

Rounds

3

Series A$9.5MFebruary 2022
Bloom Science
Bloom Science

Total Raised

$12M

Rounds

3

Series A$12MDecember 2021
Mine'd
Mine'd

Total Raised

$4.1M

Rounds

3

Seed$3.5MNovember 2021
Ombre
Ombre

Total Raised

$8.4M

Rounds

5

Seed$3MNovember 2021
Sharper Sense
Sharper Sense

Total Raised

$719k

Rounds

8

Pre-Seed$425kAugust 2021
NovoNutrients
NovoNutrients

Total Raised

$8M

Rounds

10

Seed$4.7MJuly 2021
Zone7
Zone7

Total Raised

$10.5M

Rounds

4

Series A$8MJuly 2021
Series UnknownNovember 2020
AOA Dx
AOA Dx

Total Raised

$24.6M

Rounds

5

Seed$2.5MJune 2021
Clay
Clay
Acquired

Total Raised

$3.5M

Rounds

1

Seed$3.5MJune 2021
MeliBio
MeliBio

Total Raised

$9.4M

Rounds

9

Pre-Seed$275kMarch 2021
Dame Products
Dame Products

Total Raised

$11M

Rounds

3

Seed$4MFebruary 2021
Attn: Grace
Attn: Grace

Total Raised

$5M

Rounds

6

Pre-Seed$900kDecember 2020
Nymbl Science
Nymbl Science

Total Raised

$19.8M

Rounds

10

Series A$3.7MNovember 2020
BioAesthetics
BioAesthetics

Total Raised

$6.7M

Rounds

7

Series A$6.4MOctober 2020
Eumentis Therapeutics
Eumentis Therapeutics

Total Raised

$8.9M

Rounds

4

Series A$3.9MSeptember 2020
Beelinguapp
Beelinguapp

Total Raised

$1.1M

Rounds

2

Pre-Seed$1.1MSeptember 2020
InformAI
InformAI

Total Raised

$5M

Rounds

4

Seed$1.8MJune 2020